Our NGS kits are used to detect
clonal gene rearrangements, somatic hypermutations and for the study of MRD.
Not exact matches
They also include a comprehensive bioinformatics package, enabling you to identify the DNA sequence,
clonal prevalence, and V - J family identity for each
gene rearrangement.
Since leukemias and lymphomas originate from the malignant transformation of individual lymphoid cells, all leukemias and lymphomas generally share one or more cell - specific or «
clonal» antigen receptor
gene rearrangements.
To identify and track
clonal T cell receptor (TRB)
gene rearrangements using next - generation sequencing with the Illumina MiSeq ®
Invivoscribe products identify
clonal rearrangements within the immunoglobulin and T - cell receptor
genes, which helps identify
clonal B - and T - cell populations.
These assays, developed for use with specific Next Generation Sequencing (NGS) platforms, combine optimized, proprietary multiplex PCR master mixes with a software package that converts NGS output data to an easily interpretable form, enabling you to identify the DNA sequence,
clonal prevalence, and V - J
gene identity for each
gene rearrangement.